Therapeutic Antisense Oligonucleotides Targeting NUMB Alternative Splicing in Lung Adenocarcinoma

€2.9M EUR

Funder	European Commission
Recipient Organization	Fundacio Centre de Regulacio Genomica
Country	Spain
Start Date	Apr 01, 2022
End Date	Dec 31, 2025
Duration	1,370 days
Number of Grantees	4
Roles	Participant; Coordinator
Data Source	European Commission
Grant ID	`101058055`

Grant Description

Lung cancer is the leading cause of cancer-related deaths, with 1.8 million deaths expected globally in 2021. Lung adenocarcinomas (LUAD) represent 1/3 of all lung cancer cases. Despite notable advances, current treatments remain ineffective, resulting in